[HTML][HTML] Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest. A randomized clinical trial
L Obling, R Beske, S Wiberg, F Folke, J Kjaergaard… - 2022 - researchsquare.com
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
LER Obling, RP Beske, S Wiberg, F Folke, J Kjærgaard… - ikm.ku.dk
Background: Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
LER Obling, RP Beske, S Wiberg, F Folke, JE Moeller… - Trials, 2022 - research.regionh.dk
BACKGROUND: Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a
high morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
high morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
LER Obling, RP Beske, S Wiberg, F Folke, JE Moeller… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
LER Obling, RP Beske, S Wiberg, F Folke, JE Moeller… - Trials, 2022 - search.proquest.com
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial.
LER Obling, RP Beske, S Wiberg, F Folke… - Trials, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Patients resuscitated from out-of-hospital
cardiac arrest (OHCA) have a high morbidity and mortality risk and often develop post …
cardiac arrest (OHCA) have a high morbidity and mortality risk and often develop post …
[HTML][HTML] Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial
LER Obling, RP Beske, S Wiberg, F Folke, JE Moeller… - Trials, 2022 - ncbi.nlm.nih.gov
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest: a randomized clinical trial.
LER Obling, RP Beske, S Wiberg, F Folke, JE Moeller… - Trials, 2022 - europepmc.org
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
[PDF][PDF] Steroid treatment as anti-inflammatory and neuroprotective agent following out-of-hospital cardiac arrest. A randomized clinical trial
L Obling, R Beske, S Wiberg, F Folke, J Kjaergaard… - academia.edu
Background Patients resuscitated from out-of-hospital cardiac arrest (OHCA) have a high
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …
morbidity and mortality risk and often develop post-cardiac arrest syndrome (PCAS) …